The need for rapid identification of differentially expressed genes will pe
rsist even after the complete human genomic sequence becomes available. The
most popular method for identifying differentially expressed genes acquire
s expressed sequence tags (ESTs) from the extreme 3' non-coding end of mRNA
s. Such ESTs have limitations for downstream applications. We have develope
d a method, termed preferential amplification of coding sequences (PACS), t
hat was applied to identify differentially expressed coding sequence tags (
dCSTs) between osteoblasts and osteosarcoma cells. PACS was achieved by PCR
with a set of primers to anchor at sequences complementary to AUG sequence
s in mRNAs and another set of primers to anchor at a PCR-amplifiable distan
ce from AUG sequences. An initial screen identified 103 candidate dCSTs aft
er screening similar to 15% of the expressed genes between the two cell typ
es. Of these sequences, 27 represent CSTs of known genes and two are from 3
'-ESTs of known mRNAs. Thus, PACS identified CSTs similar to 13.5 times mor
e often than it identified 3' ESTs, attesting to the objective of the metho
d. Since many of the dCSTs represent known genes, their identity and potent
ial relevance to osteosarcoma could be immediately hypothesized. Differenti
al expression of many of the dCSTs was further demonstrated by northern blo
tting or RT-PCR. Since PACS is not dependent on the existence of a poly A t
ail on an mRNA, it should have application to identify dCSTs for both proka
ryotic and eukaryotic organisms. Additionally, PACS should aid in the ident
ification of cell-specific or tissue-specific genes and bidirectional acqui
sition of cDNA sequence enabling rapid retrieval of full-length cDNA sequen
ce of novel genes. (C) 2000 Elsevier Science B.V. All rights reserved.